A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Phase of Trial: Phase IV
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Sorafenib (Primary)
- Indications Hepatitis C; Liver cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 23 Jan 2017 Status changed from recruiting to discontinued due to Slow Accrual.
- 19 Mar 2014 Status changed from suspended to recruiting as reported by ClinicalTrials.gov record.